News & Updates
Filter by Specialty:
Men with PsA derive more benefit from MTX+ETN therapy than women
09 Aug 2022
byStephen Padilla
Combination therapy with methotrexate (MTX) plus etanercept (ETN) results in more improved outcomes in men than in women with psoriatic arthritis (PsA) for minimal disease activity (MDA) and Psoriatic Arthritis Disease Activity Score (PASDAS), a study has shown.
Men with PsA derive more benefit from MTX+ETN therapy than women
09 Aug 2022Ivabradine SR improves heart function in patients with HFrEF
08 Aug 2022
Once-daily treatment with sustained-release (SR) ivabradine hemisulfate, alongside optimum standard therapy, results in better heart function in patients with chronic heart failure with reduced ejection fraction (HFrEF), reports a study.
Ivabradine SR improves heart function in patients with HFrEF
08 Aug 2022BP-lowering drug helps prevent Parkinson’s disease
08 Aug 2022
Treatment with angiotensin receptor blockers (ARBs) appears to reduce the risk of Parkinson’s disease (PD) in patients newly diagnosed with hypertension, reports a recent study.